Dr. Rinjal D. Brahmbhatt, MD

Dr. Brahmbhatt practices at North Shore Endoscopy Center - HOPD in Westlake, Ohio.

Dr. Brahmbhatt's NPI, 1417272113, was assigned on April 6, 2010. Dr. Brahmbhatt graduated from University of Wisconsin-Madison in 2010. Dr. Brahmbhatt holds Ohio license 35.130838.

Dr. Brahmbhatt's primary practice is North Shore Endoscopy Center - HOPD, at 850 Columbia Rd, Westlake, OH 44145.

Dr. Brahmbhatt's primary practice is North Shore Endoscopy Center - HOPD in Westlake, Ohio. Dr. Brahmbhatt is also affiliated with Cleveland Clinic Main Campus. The medical group on file is North Shore Gastroenterology and Endoscopy Centers. Dmand AI also links Dr. Brahmbhatt to 3 more hospitals, 3 group practices and clinics, 3 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brahmbhatt practices, 9 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Brahmbhatt's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Brahmbhatt is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Brahmbhatt's licenses on file in 4 states: Ohio, Wisconsin, Michigan and Illinois.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroenteritis, gastrointestinal bleeding and hepatitis c among the conditions Dr. Brahmbhatt treats.

CMS data shows 7,800 Medicare services from Dr. Brahmbhatt across 14 procedure codes in 2024, for 364 Medicare patients. Medicare paid $187,685 for them.

CMS counts 364 Medicare patients who saw Dr. Brahmbhatt in 2024. The largest group is 65 to 74, with 194 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brahmbhatt's median patient age at 62, with 64% women.

In 2024, Dr. Brahmbhatt wrote 815 Medicare Part D claims for 296 patients. 89% of them were for generic drugs. CMS names the drug for 652 of them, across 14 drugs with 11 or more claims each, at $825,296 in total drug cost. In 2023, CMS named 917 claims across 23 drugs.

Dr. Brahmbhatt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Brahmbhatt as offering telehealth. CMS counts 130 procedures of colonoscopy by Dr. Brahmbhatt, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Brahmbhatt in 2016. Dr. Brahmbhatt's most frequent co-authors are Rashmi M. Agni, MD, Niloo M. Edwards, MD and Michael R. Lucey, MD.

CMS Open Payments shows 216 general payments to Dr. Brahmbhatt from 35 drug and device companies from 2016 to 2025. Grants make up the largest share, 72% of the total. Madrigal Pharmaceuticals paid the most, $69,250.

Dr. Brahmbhatt graduated from University of Wisconsin-Madison in 2010.

Dr. Brahmbhatt is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.